Issue: February 2022

Read more

February 17, 2022
1 min read
Save

REVERSE-IT

Issue: February 2022
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Bentracimab (PhaseBio) for reversal of ticagrelor (Brilinta, AstraZeneca) in patients with uncontrolled major or life-threatening bleeding or undergoing an urgent invasive procedure.